Development and validation of a scoring system for late anorectal side-effects in patients treated with radiotherapy for prostate cancer

Radiotherapy and Oncology

Volumn 111, Issue 1, 2014, Pages 94-99

  Petersen, Stine Elleberg ^a   Bentzen, Lise ^a   Emmertsen, Katrine J ^a   Laurberg, Søren ^a   Lundby, Lilli ^a   Høyer, Morten ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Late morbidity; Prostate cancer; Quality of life; Radiotherapy

Indexed keywords

ANORECTAL DISEASE; ARTICLE; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; EXTERNAL BEAM RADIOTHERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY OF LIFE; QUESTIONNAIRE; RADIATION INJURY; RADIOTHERAPY INDUCED ANORECTAL DYSFUNCTION SCORE; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; VALIDATION STUDY; ADULT; AGED; AREA UNDER THE CURVE; ASSESSMENT OF HUMANS; CANCER RADIOTHERAPY; CORRELATION ANALYSIS; DEFECATION DISORDER; FECES INCONTINENCE; IMAGE GUIDED RADIOTHERAPY; INTENSITY MODULATED RADIATION THERAPY; MORBIDITY; RECEIVER OPERATING CHARACTERISTIC; ADVERSE EFFECTS; CONTROLLED STUDY; DEFECATION; MIDDLE AGED; PATHOPHYSIOLOGY; PROSTATIC NEOPLASMS; RADIATION INJURIES; RADIATION RESPONSE; RANDOMIZED CONTROLLED TRIAL; RECTUM; REGRESSION ANALYSIS; REPRODUCIBILITY;

FLUTAMIDE; GOSERELIN;

AGED; DEFECATION; HUMANS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; QUALITY OF LIFE; QUESTIONNAIRES; RADIATION INJURIES; RADIOTHERAPY; RECTUM; REGRESSION ANALYSIS; REPRODUCIBILITY OF RESULTS;

EID: 84902205278     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2014.01.023     Document Type: Article

References (42)

1. F. Bray, J. Lortet-Tieulent, J. Ferlay, D. Forman, and A. Auvinen Prostate cancer incidence and mortality trends in 37 European countries: an overview Eur J Cancer 46 2010 3040 3052
2. I.H. Derweesh, P.A. Kupelian, and C. Zippe et al. Continuing trends in pathological stage migration in radical prostatectomy specimens Urol Oncol 22 2004 300 306
3. A. Widmark, O. Klepp, and A. Solberg et al. Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial Lancet 373 2009 301 308
4. A. Bill-Axelson, L. Holmberg, and F. Filen et al. Radical prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian prostate cancer group-4 randomized trial J Natl Cancer Inst 100 2008 1144 1154
5. A.L. Potosky, W.W. Davis, and R.M. Hoffman et al. Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study J Natl Cancer Inst 96 2004 1358 1367
6. D.C. Miller, M.G. Sanda, and R.L. Dunn et al. Long-term outcomes among localized prostate cancer survivors: health-related quality-of-life changes after radical prostatectomy, external radiation, and brachytherapy J Clin Oncol 23 2005 2772 2780
7. W. Lilleby, S.D. Fossa, H.R. Waehre, and D.R. Olsen Long-term morbidity and quality of life in patients with localized prostate cancer undergoing definitive radiotherapy or radical prostatectomy Int J Radiat Oncol Biol Phys 43 1999 735 743
8. S.T. Peeters, W.D. Heemsbergen, and P.C. Koper et al. Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy J Clin Oncol 24 2006 1990 1996
9. M.J. Zelefsky, E.J. Levin, and M. Hunt et al. Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer Int J Radiat Oncol Biol Phys 70 2008 1124 1129
10. D.A. Kuban, S.L. Tucker, and L. Dong et al. Long-term results of the M.D. Anderson randomized dose-escalation trial for prostate cancer Int J Radiat Oncol Biol Phys 70 2008 67 74
11. D.P. Dearnaley, M.R. Sydes, and J.D. Graham et al. Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial Lancet Oncol 8 2007 475 487
12. Y. Maeda, M. Hoyer, L. Lundby, and C. Norton Faecal incontinence following radiotherapy for prostate cancer: a systematic review Radiother Oncol 98 2011 145 153
13. G.K. Hunter, C.A. Reddy, and E.A. Klein et al. Long-term (10-year) gastrointestinal and genitourinary toxicity after treatment with external beam radiotherapy, radical prostatectomy, or brachytherapy for prostate cancer Prost Cancer 2012 2012 853487
14. G. Goldner, N. Wachter-Gerstner, S. Wachter, K. Dieckmann, M. Janda, and R. Potter Acute side effects during 3-D-planned conformal radiotherapy of prostate cancer. Differences between patient's self-reported questionnaire and the corresponding doctor's report Strahlenther Onkol 179 2003 320 327
15. K. Kirchheiner, R. Nout, and J. Lindegaard et al. Do clinicians and patients agree regarding symptoms? A comparison after definitive radiochemotherapy in 223 uterine cervical cancer patients Strahlenther Onkol 188 2012 933 939
16. A.V. D'Amico, R. Whittington, and S.B. Malkowicz et al. Predicting prostate specific antigen outcome preoperatively in the prostate specific antigen era J Urol 166 2001 2185 2188
17. P.R. Poulsen, L. Fokdal, J. Petersen, and M. Hoyer Accuracy of image-guided radiotherapy of prostate cancer based on the BeamCath urethral catheter technique Radiother Oncol 83 2007 25 30
18. N.K. Aaronson, S. Ahmedzai, and B. Bergman et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology J Natl Cancer Inst 85 1993 365 376
19. K.J. Emmertsen, and S. Laurberg Low anterior resection syndrome score: development and validation of a symptom-based scoring system for bowel dysfunction after low anterior resection for rectal cancer Ann Surg 255 2012 922 928
20. K.J. Emmertsen, and S. Laurberg Impact of bowel dysfunction on quality of life after sphincter-preserving resection for rectal cancer Br J Surg 100 2013 1377 1387
21. C.J. Vaizey, E. Carapeti, J.A. Cahill, and M.A. Kamm Prospective comparison of faecal incontinence grading systems Gut 44 1999 77 80
22. H. Geinitz, F.B. Zimmermann, and R. Thamm et al. Late rectal symptoms and quality of life after conformal radiation therapy for prostate cancer Radiother Oncol 79 2006 341 347
23. D. Osoba, G. Rodrigues, J. Myles, B. Zee, and J. Pater Interpreting the significance of changes in health-related quality-of-life scores J Clin Oncol 16 1998 139 144
24. http://www.eortc.be/home/qol/files/SCManualQLQ-C30.pdf.
25. A. Capp, M. Inostroza-Ponta, and D. Bill et al. Is there more than one proctitis syndrome? A revisitation using data from the TROG 96.01 trial Radiother Oncol 90 2009 400 407
26. M.P. Schmid, R. Potter, and V. Bombosch et al. Late gastrointestinal and urogenital side-effects after radiotherapy - incidence and prevalence. Subgroup-analysis within the prospective Austrian-German phase II multicenter trial for localized prostate cancer Radiother Oncol 104 2012 114 118
27. W. Schaake, E.M. Wiegman, and G.M. de et al. The impact of gastrointestinal and genitourinary toxicity on health related quality of life among irradiated prostate cancer patients Radiother Oncol 110 2014 284 290
28. S.T. Peeters, J.V. Lebesque, and W.D. Heemsbergen et al. Localized volume effects for late rectal and anal toxicity after radiotherapy for prostate cancer Int J Radiat Oncol Biol Phys 64 2006 1151 1161
29. I. Syndikus, R.C. Morgan, M.R. Sydes, J.D. Graham, and D.P. Dearnaley Late gastrointestinal toxicity after dose-escalated conformal radiotherapy for early prostate cancer: results from the UK Medical Research Council RT01 trial (ISRCTN47772397) Int J Radiat Oncol Biol Phys 77 2010 773 783
30. E.K. Yeoh, R.H. Holloway, R.J. Fraser, R.J. Botten, A.C. Di Matteo, and J. Butters Pathophysiology and natural history of anorectal sequelae following radiation therapy for carcinoma of the prostate Int J Radiat Oncol Biol Phys 84 2012 e593 e599
31. P. Fransson, J.A. Lund, and J.E. Damber et al. Quality of life in patients with locally advanced prostate cancer given endocrine treatment with or without radiotherapy: 4-year follow-up of SPCG-7/SFUO-3, an open-label, randomised, phase III trial Lancet Oncol 10 2009 370 380
32. L. Fokdal, H. Honore, M. Hoyer, and M.H. von der Dose-volume histograms associated to long-term colorectal functions in patients receiving pelvic radiotherapy Radiother Oncol 74 2005 203 210
33. J.T. Wei, R.L. Dunn, and H.M. Sandler et al. Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer J Clin Oncol 20 2002 557 566
34. J.D. Cox, J. Stetz, and T.F. Pajak Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) Int J Radiat Oncol Biol Phys 31 1995 1341 1346
35. K. Krogh, P. Christensen, S. Sabroe, and S. Laurberg Neurogenic bowel dysfunction score Spinal Cord 44 2006 625 631
36. F.A. Olopade, A. Norman, and P. Blake et al. A modified inflammatory bowel disease questionnaire and the Vaizey incontinence questionnaire are simple ways to identify patients with significant gastrointestinal symptoms after pelvic radiotherapy Br J Cancer 92 2005 1663 1670
37. T. Juul, M. Ahlberg, and S. Biondo et al. International validation of the low anterior resection syndrome score Ann Surg 2013 [Epub ahead of print]
38. A.F. Engel, M.A. Kamm, and I.C. Talbot Progressive systemic sclerosis of the internal anal sphincter leading to passive faecal incontinence Gut 35 1994 857 859
39. B. O'Sullivan, and W. Levin Late radiation-related fibrosis: pathogenesis, manifestations, and current management Semin Radiat Oncol 13 2003 274 289
40. C.T. Speakman, C.H. Hoyle, and M.A. Kamm et al. Abnormal internal anal sphincter fibrosis and elasticity in fecal incontinence Dis Colon Rectum 38 1995 407 410
41. K.J. Emmertsen, S. Bregendahl, J. Fassov, K. Krogh, and S. Laurberg A hyperactive postprandial response in the neorectum - the clue to low anterior resection syndrome after TME surgery? Colorectal Dis 15 2013 e599 606 [Epub ahead of print]
42. S.M. Bentzen, H.D. Thames, and M. Overgaard Latent-time estimation for late cutaneous and subcutaneous radiation reactions in a single-follow-up clinical study Radiother Oncol 15 1989 267 274